Journals / Nöropsikiyatri Arşivi / 2013 / Cilt: 50 - Sayı: 4

Late-life Onset Mania After VareniclineUse: A Case Report

Vareniklin Kullanımı Sonrasıİleri Yaş BaşlangıçlıMani: Bir OlguSunumu

Pages
372–374
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mental state examination before and during varenicline treatment seems necessary. (Arc­hi­ves oNeu­ropsy­chi­atry 2013; 50: 372-374)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Late-life onset manic attacks generally occur secondary to general medical conditions or drug use.
📊
Key Findings & Data:Varenicline is an α4β2 nicotinic acetylcholine receptor partial agonistused for the cessation of smoking.
💡
Conclusion & Impact:Mental state examination before and during varenicline treatment seems necessary. (Arc­hi­ves oNeu­ropsy­chi­atry 2013; 50: 372-374)
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Late-life onset manic attacks generally occur secondary to general medical conditions or drug use. Varenicline is an α4β2 nicotinic acetylcholine receptor partial agonistused for the cessation of smoking. In this case report, we present a 67-year-old male patient with a new-onset manic episode following varenicline treatment. The patient’s manic symptoms started on the seventh day of varenicline treatment. His symptoms started on the 7th day of treatment. He was admitted to the psychiatric outpatient clinic since his symptoms did not improve despite discontinuing varenicline treatment. In the initial mental status examination, he scored 35/60 on the Young Mania Rating Scale (YMRS). On the twenty-fifth day of the hospitalization, the patient was discharged since his YMRS score improved (5/60). Varenicline may cause manic episodes in patients with bipolar disorder and in healthy individuals. An increasing number of serious psychiatric disorders are being reported due to varenicline treatment. Mental state examination before and during varenicline treatment seems necessary. (Arc­hi­ves oNeu­ropsy­chi­atry 2013; 50: 372-374)

Özet

İleri yaşta başlayan manik epizot genellikle tıbbi hastalık ya da ilaç kullanımına ikincil sebeplerle ortaya çıkmaktadır. Vareniklin sigara bırakma tedavisinde kullanılan α4β2 nikotinik reseptörlerin parsiyel agonistidir. Bu olguda daha önce psikiyatrik hastalık öyküsü bulunmayan 67 yaşındaki erkek hastada vareniklin kullanımı sonrası ilk kez ortaya çıkan manik epizot sunulmuştur. Vareniklin kullanımının yedinci gününde manik bulgular başladı. İlaç bırakılmasının birinci haftasında bulguların gerilememesi ile polikliniğimize başvuruldu. İlk ruhsal durum değerlendirmesinde Young Mani Değerlendirme Ölçeği (YMRS) 35/60 puan saptanmıştır. Hastane yatışının yirmi beşinci günü YMRS’nin 5/60 olması ile taburcu edildi. Vareniklin bipolar bozuklukta ve sağlıklı bireylerde manik epizoda yol açabilmektedir. Vareniklin tedavisi ile artan sayıda olguda ciddi psikiyatrik bozukluklar ortaya çıkmaktadır. Vareniklin tedavisine başlanmadan önce ve kullanımı sırasında ruhsal durum muayenelerinin değerlendirilmesi gerekli görünmektedir. (Nö­rop­si­ki­yat­ri Ar­fli­vi 2013; 50: 372-374)

🔖

Cite This Article

AKPINAR, A., ÖZDAMAR, G. Ü., ATAY, İ. M., GÜNDOĞAR, D., ÖZCANKAYA, R. (2013). Late-life Onset Mania After VareniclineUse: A Case Report. Nöropsikiyatri Arşivi, Cilt: 50 - Sayı: 4, 372–374. https://ajindex.com/articles/292546

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Van Gerpen MW, Johnson JE, Winstead DK. Mania in the geriatric patient population: a review of the literature. Am J Geriatr Psychiatry 1999; 7:188-202.
  2. Wylie ME, Mulsant BH, Pollock BG, Sweet RA, Zubenko GS, Begley AE, Gregor M, Frank E, Reynolds CF 3rd, Kupfer DJ. Age at onset in geriatric bipolar disorder. Effects on clinical presentation and treatment outcomes in an inpatient sample. Am J Geriatr Psychiatry 1999; 7:77-83.
  3. Almeida OP, Fenner S. Bipolar disorder: similarities and differences between patients with illness onset before and after 65years of age. Int Psychogeriatr 2002; 14:311-322.
  4. Kaur K, Kaushal S, Chopra SC. Varenicline for smoking cessation: a review of the literature. Curr Ther Res Clin Exp 2009;70:35-54. http//chantix.com/side-effects-safety-info.aspx. Chantix (Varenicline) tablets. Important Safety Information. Erişim tarihi Aralık 25, 2011. http://www.fda.gov/Drugs/Drugsafety/PublicHealthAdvisories/ UCM051136. Food and Drug Administration. Important Information on Chantix ( Varenicline). Erişim tarihi Aralık 25, 2011. Lyon G J. Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission. J Clin Psychopharmacol 2008; 28:720-721. Freedman R. Exacerbation of schizophrenia by varenicline. Am J Psychiatry 2007;164:1269. Pumariega AJ, Nelson R, Rotenberg L. Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS Spectrums 2008; 13:511-514. Popkin MK. Exacerbation of recurrent depression as a result of treatment with varenicline. Am J Psychiatry 2008; 165:774. Karadağ F, Oral T, Yalçın FA Ertken E. Young Mani Derecelendirme Ölçeğinin Türkiye’deGeçerlik ve Güvenilirliği. Türk Psikiyatri Dergisi 2001; 13:107-114.
  5. Güngen C, Ertan T, Eker E, Yaşar R, Engin F. Standardize Mini Mental Test’in Türk Toplumunda Hafif Demans Tanısında Geçerlik ve Güvenilirliği. Turk Psikiyatri Dergisi 2002; 13:273-281.
  6. Rollema H, Guanowsky V, Mineur YS, Shrikhande A, Coe JW, Seymour PA, Picciotto MR. Varenicline has antidepressant-like activity in the forced swim test and augments sertraline’s effect. Eur J Pharmacol 2009; 605:114-116.
  7. Cousins DA, Butts K, Young AH. The role of dopamine in bipolar disorder. Bipolar Disord 2009; 11:787-806.
  8. Alhatem F, Black JE. Varenicline-induced mania in a bipolar patient. Clin Neuropharmacol 2009; 32:117-118.
  9. Kohen I, Kremen N. Varenicline-induced manic episode in a patient